COVID-19(14) effective(8) SARS-CoV-2(8) death(8) moderate(8) vaccine.(7) Immunotherapy(6) HZ/su vaccine(6) herpes zoster(6) monoclonal antibodies(6) clinical trial(6) Postherpetic neuralgia(6) monoclonal antibody(5) pandemic(5) etesevimab(5) bamlanivimab(5) IL-6(5) Cytokine release syndrome(5) COVID-19 patients(4) approval(4) Complete(4) supportive care(4) evaluate(4) Enrollment(4) producing(4) FDA(4) screened(4) ARDS(4) Mild(4) BLAZE-1(4)